PTPN11 and type 2 diabetes mellitus: Blocking the function of SHP-2 could potentially reduce monocyte activation; however, as SHP-2 is involved in regulating various physiological functions, it was essential to identify the upstream regulators that control SHP-2 expression upregulation in T2DM conditions.